论文部分内容阅读
纤维蛋白溶酶(纤溶酶)与传统的纤溶酶原激活剂相比,具有更为理想的溶栓效果和安全性。本文对纤溶酶、微纤溶酶及小纤溶酶作为溶栓新药的研究进展作一综述。
Plasmin (plasmin) compared with the traditional plasminogen activator, has a more ideal thrombolytic effect and safety. This article reviews the progress of fibrinolytic enzyme, micro-plasmin and small plasmin as thrombolytic drugs.